Rretinal Stem And Progenitor Cells Therapy

N/A

Report date: 2022/11/05 14:17:49

Base Information

Drug NameRretinal Stem And Progenitor Cells Therapy
Drug Alias NameCultured retinal stem and progenitor cells
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Retinal stem cell therapyCell and gene therapy > Cell therapy > Somatic cell > Retinal progenitor cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelarus
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of Belarus
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of Belarus
Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A